Credit Suisse Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares China Large-Cap ETF
FXI
|
+$473M |
| 2 |
AGN
Allergan plc
AGN
|
+$384M |
| 3 |
Linde
LIN
|
+$332M |
| 4 |
McKesson
MCK
|
+$329M |
| 5 |
Broadcom
AVGO
|
+$300M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 2 |
AT&T
T
|
+$525M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$373M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$285M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$269M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.9% |
| 2 | Healthcare | 12.82% |
| 3 | Financials | 9.51% |
| 4 | Consumer Discretionary | 7.09% |
| 5 | Communication Services | 6.04% |
Similar funds
Credit Suisse's Q1 2020 Portfolio in Review
As of Q1 2020, Credit Suisse held 4,413 positions worth $116B, down 16% from $138B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse deployed $6B of net new capital in Q1 2020, opening 281 new positions and adding to 1,595 existing holdings. Its largest new stake was iShares US Healthcare Providers ETF: 4,155,000 shares worth $139M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $995M trimmed.
- Credit Suisse's largest Q1 2020 buy was iShares US Healthcare Providers ETF: 4,155,000 shares worth $139M.
- Credit Suisse added most to iShares China Large-Cap ETF in Q1 2020, an estimated $473M increase.
- Credit Suisse's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $995M.
- Credit Suisse fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $285M.
- Credit Suisse's ten largest holdings make up 17% of its $116B portfolio in Q1 2020.
- Credit Suisse opened 281 new positions and closed 461 in Q1 2020.
- Credit Suisse's portfolio value fell 16% quarter-over-quarter to $116B.
Based on Credit Suisse's 13F filing for Q1 2020, filed 13 May 2020.